Global Antimicrobial Resistance Surveillance System (GLASS)
Surveillance of antimicrobial resistance
In May 2015, the Sixty-eighth World Health Assembly adopted the global action plan on antimicrobial resistance. One of the five strategic objectives of the action plan is to strengthen the evidence base through enhanced global surveillance and research.
AMR surveillance is the cornerstone for assessing the burden of AMR and for providing the necessary information for action in support of local, national and global strategies. The Global Antimicrobial Resistance Surveillance System (GLASS) is being launched to support a standardized approach to the collection, analysis and sharing of data on AMR at a global level, in order to inform decision-making, drive local, national and regional action, and provide the evidence base for action and advocacy.
GLASS aims to combine clinical, laboratory and epidemiological data on pathogens that pose the greatest threats to health globally. The GLASS manual details the proposed approach for the early implementation of the surveillance system, that will focus on antibiotic-resistant bacteria, and outlines the flexible and incremental development of the system over time that will incorporate lessons learned from the early implementation phase.
Participation in GLASS
Countries can benefit from participation in GLASS through enhanced capacity building, access to training and implementation tools, and support in collecting AMR data at local and national levels. Country participation in GLASS must be with the agreement of the national government.
Call for country enrollment in the Global Antimicrobial Resistance Surveillance (GLASS) is now open.